Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
7.90
+0.12 (1.54%)
Dec 20, 2024, 4:00 PM EST - Market closed
Addex Therapeutics Balance Sheet
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 3.35 | 3.87 | 6.96 | 20.48 | 18.7 | 31.54 | Upgrade
|
Cash & Short-Term Investments | 3.35 | 3.87 | 6.96 | 20.48 | 18.7 | 31.54 | Upgrade
|
Cash Growth | -29.55% | -44.44% | -66.04% | 9.57% | -40.72% | -24.32% | Upgrade
|
Receivables | 0.52 | 0.15 | 0.6 | 0.32 | 0.07 | 0.12 | Upgrade
|
Prepaid Expenses | 0.2 | 0.22 | 0.27 | 1.12 | 0.5 | 0.72 | Upgrade
|
Other Current Assets | 0.01 | 0 | 0 | 0.02 | 0.23 | 0.01 | Upgrade
|
Total Current Assets | 4.07 | 4.23 | 7.83 | 21.94 | 19.49 | 32.39 | Upgrade
|
Property, Plant & Equipment | 0.04 | 0.35 | 0.4 | 0.54 | 0.63 | 0.57 | Upgrade
|
Other Intangible Assets | 0.02 | - | - | - | - | - | Upgrade
|
Other Long-Term Assets | 0.01 | 0.05 | 0.05 | 0.06 | 0.06 | 0.07 | Upgrade
|
Total Assets | 12.17 | 4.64 | 8.28 | 22.54 | 20.18 | 33.03 | Upgrade
|
Accounts Payable | 0.33 | 0.98 | 1.28 | 1.79 | 0.98 | 2.22 | Upgrade
|
Accrued Expenses | 0.55 | 1.4 | 1.72 | 2.06 | 1.51 | 1.98 | Upgrade
|
Current Portion of Leases | 0.01 | 0.27 | 0.29 | 0.29 | 0.31 | 0.37 | Upgrade
|
Current Unearned Revenue | - | 0.23 | - | - | 0.82 | 1.11 | Upgrade
|
Total Current Liabilities | 0.89 | 2.89 | 3.28 | 4.13 | 3.62 | 5.68 | Upgrade
|
Long-Term Leases | 0.04 | 0.07 | 0.09 | 0.19 | 0.26 | 0.18 | Upgrade
|
Long-Term Unearned Revenue | - | 0.09 | - | - | - | 0.17 | Upgrade
|
Total Liabilities | 1.11 | 3.5 | 3.37 | 5.61 | 5.57 | 7.5 | Upgrade
|
Common Stock | 1.84 | 1.84 | 1.15 | 49.27 | 32.85 | 32.85 | Upgrade
|
Additional Paid-In Capital | 266.38 | 266.19 | 269.51 | 283.98 | 286.89 | 286.38 | Upgrade
|
Retained Earnings | -352.16 | -360.42 | -349.86 | -329.06 | -313.71 | -300.85 | Upgrade
|
Treasury Stock | -0.87 | -0.91 | -6.28 | -11.7 | -6.08 | -6.57 | Upgrade
|
Comprehensive Income & Other | 95.86 | 94.44 | 90.39 | 24.44 | 14.66 | 13.72 | Upgrade
|
Shareholders' Equity | 11.06 | 1.15 | 4.91 | 16.93 | 14.61 | 25.52 | Upgrade
|
Total Liabilities & Equity | 12.17 | 4.64 | 8.28 | 22.54 | 20.18 | 33.03 | Upgrade
|
Total Debt | 0.04 | 0.34 | 0.37 | 0.48 | 0.57 | 0.55 | Upgrade
|
Net Cash (Debt) | 3.31 | 3.52 | 6.58 | 20 | 18.13 | 30.99 | Upgrade
|
Net Cash Growth | -25.40% | -46.52% | -67.08% | 10.34% | -41.50% | -25.64% | Upgrade
|
Net Cash Per Share | 0.03 | 0.05 | 0.15 | 0.59 | 0.68 | 1.17 | Upgrade
|
Filing Date Shares Outstanding | 98.32 | 128.26 | 80.88 | 37.9 | 27.12 | 26.61 | Upgrade
|
Total Common Shares Outstanding | 98.32 | 125.2 | 77.13 | 37.9 | 27.12 | 26.61 | Upgrade
|
Working Capital | 3.18 | 1.34 | 4.55 | 17.81 | 15.87 | 26.71 | Upgrade
|
Book Value Per Share | 0.11 | 0.01 | 0.06 | 0.45 | 0.54 | 0.96 | Upgrade
|
Tangible Book Value | 11.04 | 1.15 | 4.91 | 16.93 | 14.61 | 25.52 | Upgrade
|
Tangible Book Value Per Share | 0.11 | 0.01 | 0.06 | 0.45 | 0.54 | 0.96 | Upgrade
|
Machinery | 0.08 | 1.73 | 1.72 | 1.72 | 1.69 | 1.63 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.